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Background
Alzheimer’s disease (AD) is a common neurodegenerative
disorder that leads to cognitive impairment. In India, the
prevalence of AD is currently ~3.5 million but due to its
large population and the recent increase in longevity, is
projected to increase to 7-9 million by 2020. Thus, AD is a
significant burden of disease in our country. Genetic varia-
tions play a major role in AD. The apolipoprotein-E gene
and in particular its ε4 allele account for 20-50% of
the total genetic variance in disease risk. One copy of ε4
allele increases risk for AD by ~threefold, and two copies,
by more than ten-fold. But still, ε4 allele is neither necessary
nor sufficient for the development of the disease, indicating
involvement of other genetic risk factors, alone or in con-
junction with the ε4 allele underlying disease predisposition.
Materials and methods
Patient derived Lymphoblastoid cells (LCLs) carrying pre-
disposing APOE4 allele was used to generate induced
pluripotent stem cells (iPSCs) using episomal plasmids.
Post characterization, theiPSC lines were differentiated
into neuronal lineage using retinoic acid induction
method. Whole genome transcriptome analysis was per-
formed using RNA isolated from MAP2/Tuj1 positive
cells (17-22 DIV). Protein expression studies (by Western
Blot) for key molecules was also performed to validate the
above results.
Results
We have successfully generated iPSC lines from AD
patients and cognitively normal controls (n=6). These
lines display human embryonic stem-cell like morphology
and transcription profile. These cells gave rise to neurons
on directed differentiation that were positive for neuronal
markers MAP2 and Tuj1. Whole genome transcriptome
analysis of differentiating neurons derived from patient
iPSCs with varying APOE genotype showed significant
differential expression of coding and pseudogenes
in implicated pathways. Briefly, genes encoding for
focal adhesion molecules, glutamatergic synapses, axon
guidance and cell adhesion protein showed differential
expression patterns. Preliminary protein expression studies
performed on parent LCL lines have confirmed some of
transcriptome signals suggesting usefulness of peripheral
models to interrogate complex phenotypes like AD.
Conclusion
Most patient-specific iPSC lines reported use viral trans-
duction as the mode of gene delivery for reprogramming.
This may affect the phenotype and mechanism of the
disease in question. We have generated iPSC lines using
an integration-free method using LCLs. the derived LCL
lines are stable for a large number of passages and serve as
an alternate cell model to test experimental leads. As a
preliminary step to test the validity of patient derived
iPSCs to model AD, we have used whole genome RNA
sequencing analysis. We show APOE allele- specific
difference in expression profile of genes in key disease
pathways. We are currently validating these leads in
a larger patient sample.
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